A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
First in Human, Dose Escalation, Dose Expansion Study of AUR105
- Status
- TERMINATED
- Phase
- PHASE1
Improving Exercise Capacity With a Tailored Physical Activity Intervention
- Status
- RECRUITING
- Phase
- NA
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
- Status
- COMPLETED
- Phase
- PHASE2
Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs
- Status
- UNKNOWN
- Phase
- N/A
MargheRITA (Remote Intelligence for Therapeutic Adherence)
- Status
- COMPLETED
- Phase
- NA
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
- Status
- RECRUITING
- Phase
- N/A
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
- Status
- COMPLETED
- Phase
- NA
A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE3
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2